Characterization of thiobarbituric acid derivatives as inhibitors of hepatitis C virus NS5B polymerase
2011

Inhibitors of Hepatitis C Virus Polymerase

Sample size: 6500 publication Evidence: moderate

Author Information

Author(s): Lee Jong-Ho, Lee Sangyoon, Park Mi Young, Myung Heejoon

Primary Institution: Hankuk University of Foreign Studies

Hypothesis

Can thiobarbituric acid derivatives inhibit the enzymatic activity of hepatitis C virus NS5B polymerase?

Conclusion

Thiobarbituric acid derivatives were found to inhibit the hepatitis C virus NS5B polymerase, particularly the compound G05, which acts as a noncompetitive inhibitor.

Supporting Evidence

  • The selected compounds exhibited IC50 values ranging from 1.7 to 3.8 μM against NS5B polymerase of type 1b strain.
  • G05 inhibited the synthesis of RNA by recombinant HCV NS5B polymerase in a dose-dependent manner.
  • The CC50 value for G05 was 77 μM, indicating its safety margin in cell viability.

Takeaway

Scientists tested a lot of chemicals to see if they could stop a virus from making copies of itself, and they found some that worked really well.

Methodology

A chemical library was screened using a bacterial cell-based assay, and the inhibitory effects were tested using a [32P]-UMP incorporation assay.

Limitations

The study primarily focused on type 1b strain of HCV and did not explore the effects on other strains extensively.

Digital Object Identifier (DOI)

10.1186/1743-422X-8-18

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication